GMP Tips

A portal for Good Manufacturing Practice compliance tips for the Life Sciences industries.

GMP Tips header image 2

Florida drug company hit with Consent Decree

October 11th, 2011 · No Comments · Uncategorized

The U.S. FDA announced that the District Court for the Middle District of Florida entered a consent decree that prohibits Hill Dermaceuticals, Inc., and Hill Labs, Inc. from introducing adulterated drugs into interstate commerce.

This Consent Decree describes numerous deviations from current good manufacturing practice (cGMP) for drugs documented during the FDA’s inspections of Hill. FDA  further alleges that Hill has, on more than one occasion, submitted untrue statements in support of submissions to the FDA. These falsified submissions are evidence of persistent data integrity problems at Hill.

Read FDA’s Press Release. Go to:
Click on Timely Resource Articles

Serving 1951 clients since 1989

Upcoming Boot Camps
Click below for our 2011/2012 schedule

GMP Boot Camp – Fundamentals of GMP and QSR
Oct 19 – 20  Newark, NJ

Upcoming web seminars
Cost effective & Convenient – in your office or conference room

How to Conduct a Successful Supplier Audit: Protecting Your Supply Chain
Oct 14

Implementing FDA’s Guidance on a Quality Systems Approach to Pharmaceutical cGMP Regulations
Oct 28

Outsourcing in the Healthcare Industry: Avoiding the Perils and Pitfalls
Nov 4

How to Implement FDA’s New Guidance on Process Validation
Nov 11

ASTM E2500 Consensus Standard: An Overview of a New Approach to Validation
Nov 18

Proven Steps to Reducing Waste in Process Validation
Dec 2

Please forward this to others in your organization who may benefit.


No Comments so far ↓

Like gas stations in rural Texas after 10 pm, comments are closed.